| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.09 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |